Clinical Trials Browser

Withdrawn × INDUSTRY × Central Nervous System Neoplasms × Clear all

NCT05222165 2023-02-23

NEWEL

Phase 1/2 Withdrawn

Central Nervous System Neoplasms

NCT00814593 2019-05-10

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Phase 2 Withdrawn

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma